Sort
10,766 grants matching “checkpoint inhibitor”
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$287,999Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2023 · CA
Modulation of Microglia and T Cell Interactions in Malignant Glioma
$287,999Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2025 · CA
Project 1
$287,916Ann G Schwartz · Wayne State University · P20 · FY2023 · CA
Targeted Therapy for Endometrial Cancer
$287,850Kimberly K Leslie · University Of New Mexico Health Scis Ctr · R01 · FY2023 · CA
Cyclin-Dependent Kinase Inhibition During S Phase
$287,802Geoffrey I Shapiro · Dana-Farber Cancer Inst · R01 · FY2013 · CA
Mechanisms that coordinate cell size with mitotic entry
$287,688James B Moseley · Dartmouth College · R01 · FY2013 · GM
Modulators of p53 Expression and Function
$287,640Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
Modulators of p53 Expression and Function
$287,640Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2003 · CA
Modulators of p53 Expression and Function
$287,640Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA
Islet Growth Factors Transgenic and Viral Modeling
$287,606Andrew F. Stewart · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · DK
Human Translational Studies of Vascular Thrombosis and Inflammation
$287,073Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
HTLV-I Tax activates the anaphase promoting complex
$286,847Chou-Zen Giam · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2010 · CA
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations
$286,658Brian C Miller · Univ Of North Carolina Chapel Hill · K08 · FY2024 · CA
Targeting Unique Meyloid Populations to Overcome Anti-PD-1 Resistance Conferred by Specific Cancer Mutations
$286,658Brian C Miller · Univ Of North Carolina Chapel Hill · K08 · FY2023 · CA
Project 2: Discovery and validation of novel molecular and immune predictors of colorectal cancer mortality and response to treatment in racially and ethnically diverse patient populations
$286,521Christopher I Li · Fred Hutchinson Cancer Center · P50 · FY2024 · CA
The role of DNA damage response in chronic kidney disease
$286,411Rannar Airik · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Regulation of Replication Checkpoint by Proteolysis
$286,125Yale University · R01 · FY2005 · CA
Regulation of Replication Checkpoint by Proteolysis
$286,125Yale University · R01 · FY2004 · CA
The integrated stress response and the microenvironment in melanoma progression
$285,994Constantinos Koumenis · University Of Pennsylvania · R01 · FY2025 · CA
Administrative/Clinical Trials Core
$285,935Kirby I Bland · University Of Alabama At Birmingham · P50 · FY2007 · CA
Project 2
$285,839Rory Smoot · Mayo Clinic Rochester · P50 · FY2025 · CA
STINGing GBM: A First-in- Man Clinical Trial in Surgical Resectable Recurrent GBM
$285,775Amy Beth Heimberger · Northwestern University At Chicago · P50 · FY2023 · CA
Intestinal Cell Growth Control: Role of Tyrosine Kinases
$285,680Christine Ann Cartwright · Stanford University · R01 · FY2008 · DK
Intestinal Cell Growth Control: Role of Tyrosine Kinases
$285,680Christine Ann Cartwright · Stanford University · R01 · FY2009 · DK
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit
$285,608Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2013 · CA